AHRQ Vitamin D/Calcium Report Draws Industry Fire
This article was originally published in The Tan Sheet
Executive Summary
The U.S. Preventive Service Task Force releases a meta-analysis looking at whether available research supports an association between the use of vitamin D and calcium and fracture prevention. Trials of vitamin D use alone or with calcium showed no statistically significant reduction in fractures among subjects in the control groups, the panel found.
You may also be interested in...
Regenerating Interest In Novel Drugs For Postmenopausal Osteoporosis
New bone-targeted agents for osteoporosis must clear significant obstacles to succeed in a highly generic market, but safety concerns with established agents like bisphosphonates and calcitonin offer a foothold. Phase III anabolic candidates from Amgen and Radius Health aim to build new bone, the holy grail of osteoporosis treatment, but R&D in new anti-resorptive mechanisms to halt bone breakdown also continues.
Nutrition Scientists Float “Least-Harm Strategy” To Allow Health Claims
Presenters at the IFT Wellness conference recommend that nutrition science move beyond randomized controlled trials – which typically are ill-suited to assess nutrient benefits – so development of new food and supplement products is not impeded.
IoM Sets Vitamin D Intake Levels Below Experts' Expectations
The Institute of Medicine sets its daily vitamin D daily allowance well below the amounts some nutrition experts suggest.